William Kushner

Will is an effective, business-minded attorney with deep experience serving healthcare, technology, social media and consumer products clients for over 20 years. He combines his General Counsel experience serving mBlox and Oncology Therapeutics Network/Bristol-Myers Squibb to provide superior, timely results.

Both as corporate counsel and in private legal practice, Will has handled dozens of complex M&A deals ranging from $5M to over $500M, and a broad range of debt and equity financings. Will possesses a deep understanding of his clients’ business requirements, which enables him to execute deals on terms and timescales that work.

Additionally, he has significant experience with intellectual property protection, global compliance, litigation management and commercial initiatives. Will’s clients compete in highly regulated industries including healthcare/life sciences, social media, gaming, consumer products, SaaS and telecom.

Supplementing his legal experience, from 2008 to 2010, Will was a principal of an investment bank based in New York, where he was a M&A advisor on biopharma and healthcare IT transactions and also helped to form and secure private financing for ZS Pharma (NASDAQ: ZSPH), a specialty pharma company. Through this experience, Will developed corporate finance skills that position him uniquely as a trusted business advisor who can help structure financing transaction far better legal counsel who has never been on the front line.

Representative Transactions & Assignments

M&A/Corporate Finance (Healthcare)

  • $210M divestiture of BMS’ specialty pharmaceutical distribution business, followed by series of strategic acquisitions including specialty pharmacy and specialty distribution facility
  • Sale of specialty health services & data analytics business for $575M to McKesson Corporation
  • $350M revolving line of credit for pharmaceutical distribution business
  • Preferred Stock financings totalling over $500M
  • Transfer tax studies and tax-driven restructurings
  • Joint venture with physician organization
  • Phantom stock plan for CRO analytics provider

M&A/Corporate Finance (Technology and Social Media/Gaming)

  • Merger of equals with approximately $75M of paid-in capital to form mobile analytics and marketing platform
  • Preferred Stock financings totaling over $250M for A/B testing, social gaming, mobile ad software and other technology companies
  • Acquisitions and sales involving technology assets

Litigation Management

  • Collection of £5M award in arbitration of commercial dispute in the UK
  • Defendant in consumer protection and antitrust class action litigation involving US-based wireless carriers
  • Defendant in Federal Multi-district litigation (pharmaceutical pricing)
  • Respondent to numerous subpoena from local, State and Federal agencies
  • Plaintiff in claim against McKesson for breach of contract
  • Defendant in employment matters including workers compensation & wrongful termination


  • Game development and publisher arrangements with leading casino operators
  • Licensing of location-based services modules for A/B testing provider
  • Authorized generic arrangement for Bristol-Myers Squibb
  • Authorized distribution arrangements with global generics manufacturers
  • Manufacturing, conjugation and logistics arrangements with radiopharmaceutical manufacturers
  • Exclusive hardware and software re-seller arrangements
  • SaaS agreements for healthcare and technology vendors

Government Contracting

  • CMS (Medicare) Competitive Acquisition Program for specialty pharmaceuticals
  • Pharmaceutical Pricing Agreement with Veterans Administration
  • Medicaid Pharmaceutical Pricing Agreements
  • University of California pharmaceutical supplier contract